Contraindications and Risks of Lomotil in Bacterial Gastroenteritis

Introduction to Risks

Slowing intestinal motility when invasive pathogens are present leads to bacterial proliferation within the gut, toxin accumulation rather than expulsion, and risk of toxic megacolon, a potentially fatal complication 1

Before considering any antimotility agent, screen for absolute contraindications such as fever, frank blood in stool, severe abdominal pain or distention, and known or suspected invasive bacterial infection 1
If any of these warning signs are present, do not use Lomotil 1

Loperamide may be given safely in immunocompetent adults with watery diarrhea while awaiting stool culture results, but repeated clinical assessment is essential to detect early signs of toxic dilatation, especially in neutropenic patients 2, 1
Loperamide should be stopped immediately if fever, blood in stool, or abdominal distention develops 1
Lomotil has a more pronounced effect on intestinal transit than loperamide and carries greater risk of central nervous system effects 3

Immunocompromised patients are at particularly high risk of toxic megacolon with invasive pathogens and should avoid all antimotility agents in suspected bacterial gastroenteritis 1
Children under 18 years should never receive antimotility drugs for acute diarrhea due to risks of respiratory depression and cardiac adverse reactions 1, 3

Appropriate management of bacterial gastroenteritis includes rehydration as the first priority 1
Stool culture to identify the causative organism is also recommended 2